Related Experiment Video
Updated: Aug 11, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
[Role of non-steroidal anti-inflammatory drugs on upper gastrointestinal bleeding]
Marian Sułek1, Marta Steinbrich-Zoller, Anna Dudek
1Wojskowy Instytut Medyczny, Klinika Chorób Wewnetrznych i Reumatologii CSK MON w Warszawie.
Unlabelled:
Peptic ulcer is a common complication of upper gastrointestinal (uGI) bleeding, which refers to 20% of patients with duodenal and gastric ulcer. Non-steroidal anti-inflammatory drugs (NSAIDs) use is a well-known risk factor for ulcer formation and uGI bleeding.
Aim Of The Study:
The evaluation of location and the cause od uGI bleeding and its association with NSDAIDs use.
Material And Methods:
We conducted a retrospective analysis of all patients hospitalized in our department from 2000 to 2001.
Results:
Upper gastrointestinal bleeding was an indication for 3% of hospitalizations in our department. The cause of the bleeding was as follows: NSAIDs use side effect in 21 (42%) patients, portal hypertension in 6 (12%), acenocumarol overdosage in 2 (4%), not specified in 17 (34%). 13 (62%) of 21 NSAIDs-users chronically ingested small doses of acetylsalicylic acid. The most common sources of bleeding were: duodenal ulcer in 20 (40%), gastric or esophageal ulcer in 10 (20%), erosive gastroduodenitis in 8 (16%), esophageal varices in 6 (12%), not specified in 2 (4%) and not specified after acenocumarol overdosage in 2 (4%). One patient had coexisting gastric and duodenal ulcers, and one patient had coexisting erosive gastritis and duodenal ulcer In NSAIDs-users group, there were 9 (43%) patients with erosive gastroduodenitis, 8 (38%) with duodenal ulcer and 4 (19%) with gastric ulcer.
Conclusion:
On the basis of our observations we concluded that NSAIDs use (especially cardiological doses of acetylsalicylic acid) is a common cause of upper gastrointestinal bleeding. The most common source of bleeding in this group was erosive gastroduodenitis. The age over 65 years was an additional risk factor for uGI bleeding.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...